366 related articles for article (PubMed ID: 3130927)
1. Malaria chemoprophylaxis in travellers to east Africa: a comparative prospective study of chloroquine plus proguanil with chloroquine plus sulfadoxine-pyrimethamine.
Fogh S; Schapira A; Bygbjerg IC; Jepsen S; Mordhorst CH; Kuijlen K; Ravn P; Rønn A; Gøtzsche PC
Br Med J (Clin Res Ed); 1988 Mar; 296(6625):820-2. PubMed ID: 3130927
[TBL] [Abstract][Full Text] [Related]
2. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa.
Steffen R; Fuchs E; Schildknecht J; Naef U; Funk M; Schlagenhauf P; Phillips-Howard P; Nevill C; Stürchler D
Lancet; 1993 May; 341(8856):1299-303. PubMed ID: 8098447
[TBL] [Abstract][Full Text] [Related]
3. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
Llanos-Cuentas A; Campos P; Clendenes M; Canfield CJ; Hutchinson DB
Braz J Infect Dis; 2001 Apr; 5(2):67-72. PubMed ID: 11493411
[TBL] [Abstract][Full Text] [Related]
4. Malaria prophylaxis in travellers to tropical Africa.
Weinke T; Weber G; Schultes U; Hopfenmüller W; Janitschke K
Klin Wochenschr; 1990 Mar; 68(5):277-80. PubMed ID: 2182940
[TBL] [Abstract][Full Text] [Related]
5. Atovaquone and proguanil versus pyrimethamine/sulfadoxine for the treatment of acute falciparum malaria in Zambia.
Mulenga M; Sukwa TY; Canfield CJ; Hutchinson DB
Clin Ther; 1999 May; 21(5):841-52. PubMed ID: 10397379
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three regimens for malaria prophylaxis in travellers to east, central, and southern Africa.
Wetsteyn JC; de Geus A
BMJ; 1993 Oct; 307(6911):1041-3. PubMed ID: 8123120
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of malaria prophylaxis in American and Swiss travelers to Kenya.
Lobel HO; Roberts JM; Somaini B; Steffen R
J Infect Dis; 1987 Jun; 155(6):1205-9. PubMed ID: 3553347
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
9. Sulfadoxine-pyrimethamine for the treatment of acute malaria in children in Papua New Guinea. I. Plasmodium falciparum.
Darlow B; Vrbova H; Gibney S; Jolley D; Stace J; Alpers M
Am J Trop Med Hyg; 1982 Jan; 31(1):1-9. PubMed ID: 7036764
[TBL] [Abstract][Full Text] [Related]
10. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
Pearson RD; Hewlett EL
Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
[TBL] [Abstract][Full Text] [Related]
11. Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.
Miller KD; Lobel HO; Pappaioanou M; Patchen LC; Churchill FC
J Infect Dis; 1986 Oct; 154(4):689-91. PubMed ID: 3528321
[No Abstract] [Full Text] [Related]
12. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.
Mutabingwa T; Nzila A; Mberu E; Nduati E; Winstanley P; Hills E; Watkins W
Lancet; 2001 Oct; 358(9289):1218-23. PubMed ID: 11675058
[TBL] [Abstract][Full Text] [Related]
13. The chemoprophylaxis of malaria.
Chiodini PL
J Antimicrob Chemother; 1987 Sep; 20(3):297-302. PubMed ID: 3316145
[No Abstract] [Full Text] [Related]
14. Sensitivity in vivo of Plasmodium falciparum to chloroquine and pyrimethamine/sulfadoxine in a coastal area of Tanzania.
Hedman P; Rombo L; Björkman A; Brohult J; Kihamia CM; Potter J; Stenbeck J
Ann Trop Med Parasitol; 1986 Feb; 80(1):7-11. PubMed ID: 3524485
[TBL] [Abstract][Full Text] [Related]
15. Atovaquone-proguanil compared with chloroquine and chloroquine-sulfadoxine-pyrimethamine for treatment of acute Plasmodium falciparum malaria in the Philippines.
Bustos DG; Canfield CJ; Canete-Miguel E; Hutchinson DB
J Infect Dis; 1999 Jun; 179(6):1587-90. PubMed ID: 10228090
[TBL] [Abstract][Full Text] [Related]
16. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
[TBL] [Abstract][Full Text] [Related]
17. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
[TBL] [Abstract][Full Text] [Related]
18. Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial.
Divala TH; Mungwira RG; Mawindo PM; Nyirenda OM; Kanjala M; Ndaferankhande M; Tsirizani LE; Masonga R; Muwalo F; Boudová S; Potter GE; Kennedy J; Goswami J; Wylie BJ; Muehlenbachs A; Ndovie L; Mvula P; Mbilizi Y; Tomoka T; Laufer MK
Lancet Infect Dis; 2018 Oct; 18(10):1097-1107. PubMed ID: 30195996
[TBL] [Abstract][Full Text] [Related]
19. Leads from the MMWR. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
JAMA; 1986 Feb; 255(5):597. PubMed ID: 3003409
[No Abstract] [Full Text] [Related]
20. Combined chloroquine/Fansidar-resistant falciparum malaria appears in East Africa.
Hess U; Timmermans PM; Jones M
Am J Trop Med Hyg; 1983 Mar; 32(2):217-20. PubMed ID: 6340538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
